SuperworthTango Therapeutics market cap TNGX
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $3.9B
- Highest close in our data
- $4.6B
- Jun 2026
Tango Therapeutics is worth $3.9B at the close on Oct 23, 2026, at $23.34 a share.
That is up 372% over the last year and up 1334% over five years.
Its highest close in our data was $4.6B in Jun 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3.9B | $1.2B | $4.6B | +237% |
| 2025 | $1.2B | $123.2M | $1.5B | +248% |
| 2024 | $335.1M | $316.9M | $1.3B | −62% |
| 2023 | $875.8M | $264.3M | $1B | +37% |
| 2022 | $639.3M | $301.1M | $816.8M | −33% |
| 2021 | $957.8M | $211M | $1.2B | +292% |
| 2020 | $244.6M | $221M | $244.6M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Tango Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| TNGXTango Therapeutics | $3.9B |
| ARQTArcutis Biotherapeutics | $3.9B |
| LQDALiquidia | $3.8B |
| INDVIndivior Pharmaceuticals | $4.1B |
| OGNOrganon | $3.6B |
| NRIXNurix Therapeutics | $2.8B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| PBHPrestige Consumer Healthcare | $2.3B |
| ALKSAlkermes plc. | $7.3B |
| Peer median | $4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Tango Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.